Healius (ASX:HLS) Long-Term Debt: A$761 Mil (As of Dec. 2025)


ASX:HLS Healius Ltd ASX:HLS
49 GF Score
Price A$0.37
GF Value A$1.01
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Healius Long-Term Debt?

Healius ASX:HLS -5.13% 49 Long-Term Debt is A$761 Mil as of Dec. 2025. GuruFocus rates ASX:HLS with a GF Score™ of 49/100 and a GF Value™ of A$1.01 (Possible Value Trap). The stock has 7 warning signs investors should review.

Healius's Long-Term Debt for the quarter that ended in Dec. 2025 was A$761 Mil.

Healius's quarterly Long-Term Debt declined from Dec. 2024 (A$1,224 Mil) to Jun. 2025 (A$0 Mil) but then increased from Jun. 2025 (A$0 Mil) to Dec. 2025 (A$761 Mil).

Healius's annual Long-Term Debt declined from Jun. 2023 (A$562 Mil) to Jun. 2024 (A$421 Mil) and declined from Jun. 2024 (A$421 Mil) to Jun. 2025 (A$0 Mil).

Healius  (ASX:HLS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Healius Long-Term Debt Related Terms

Healius Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Healius's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healius Long-Term Debt Chart

Healius Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 518.90 606.10 562.10 420.80 0.00

Healius Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,352.20 420.80 1,223.60 0.00 761.40
ASX:HLS
49GF Score
Healius Ltd ASX:HLS
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of A$761 Mil mean?
Healius (ASX:HLS) has a Long-Term Debt of A$761 Mil as of Dec. 2025.
Is Healius' Long-Term Debt too high?
Healius' current Long-Term Debt is A$761 Mil. Overall, Healius has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Healius' Long-Term Debt compare to TMO and DHR?
Healius' Long-Term Debt of A$761 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Healius's current Long-Term Debt is A$761 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healius stock overvalued right now?
Based on GuruFocus' analysis, Healius (ASX:HLS) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.01, compared to a current price of A$0.37 — trading 63.4% below its estimated fair value. The current Long-Term Debt is A$761 Mil. Healius' overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Healius (ASX:HLS), the current Long-Term Debt is A$761 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healius (ASX:HLS) Overvalued in 2026?

Based on GuruFocus' analysis, Healius stock appears to be undervalued. The current stock price of A$0.37 is trading 63.4% below its estimated GF Value™ of A$1.01. GuruFocus considers Healius to be Possible Value Trap.

Key valuation signals for ASX:HLS:

  • Long-Term Debt: A$761 Mil
  • GF Value™: A$1.01 vs. price of A$0.37 (63.4% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the ASX:HLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healius Business Description

Other Exchanges PGZ:Germany
Address 161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider. Pathology revenue is almost entirely earned via the public health Medicare system and makes up the majority of Healius' group revenue. A small portion comes from its clinical testing business, Agilex.
49GF Score

Get the complete analysis for ASX:HLS

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.37
Price
A$1.01
GF Value